Insider Transactions in Q1 2021 at Generation Bio Co. (GBIO)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,000,000
-9.89%
|
-
|
|
Mar 10
2021
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,500
-2.55%
|
$357,000
$34.92 P/Share
|
|
Mar 10
2021
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+4.79%
|
$0
$0.6 P/Share
|
|
Mar 05
2021
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,267
-0.48%
|
$360,544
$32.79 P/Share
|
|
Mar 05
2021
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,267
+3.23%
|
$45,068
$4.59 P/Share
|
|
Mar 03
2021
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-100.0%
|
$123,000
$41.38 P/Share
|
|
Mar 03
2021
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$12,000
$4.59 P/Share
|
|
Mar 01
2021
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
2,500
-48.95%
|
$95,000
$38.61 P/Share
|
|
Mar 01
2021
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$10,000
$4.59 P/Share
|
|
Mar 01
2021
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
10,000
-0.28%
|
$370,000
$37.3 P/Share
|
|
Feb 10
2021
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,400
-1.69%
|
$353,600
$34.64 P/Share
|
|
Feb 10
2021
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,400
+4.75%
|
$0
$0.6 P/Share
|
|
Feb 08
2021
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,267
-1.68%
|
$371,811
$33.55 P/Share
|
|
Feb 08
2021
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,267
+3.23%
|
$45,068
$4.59 P/Share
|
|
Feb 02
2021
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$82,500
$33.05 P/Share
|
|
Feb 02
2021
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$10,000
$4.59 P/Share
|
|
Jan 15
2021
|
Mark D. Angelino CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
7,500
-0.53%
|
$247,500
$33.64 P/Share
|
|
Jan 15
2021
|
Mark D. Angelino CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+2.08%
|
$30,000
$4.59 P/Share
|
|
Jan 14
2021
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,630
-1.39%
|
$180,160
$32.56 P/Share
|
|
Jan 14
2021
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,630
+2.69%
|
$0
$0.6 P/Share
|
|
Jan 14
2021
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$82,500
$33.09 P/Share
|
|
Jan 14
2021
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$10,000
$4.59 P/Share
|
|
Jan 13
2021
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Bona fide gift
|
Indirect |
275,000
+50.0%
|
-
|
|
Jan 13
2021
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Bona fide gift
|
Direct |
275,000
-18.59%
|
-
|
|
Jan 11
2021
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
20,408
+16.8%
|
$489,792
$24.5 P/Share
|
|
Jan 11
2021
|
Donald William Nicholson |
BUY
Open market or private purchase
|
Direct |
4,081
+3.81%
|
$97,944
$24.5 P/Share
|
|
Jan 11
2021
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
14,820
-2.36%
|
$400,140
$27.99 P/Share
|
|
Jan 11
2021
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,820
+6.51%
|
$0
$0.6 P/Share
|
|
Jan 11
2021
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,267
-1.12%
|
$315,476
$28.01 P/Share
|
|
Jan 11
2021
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,267
+3.23%
|
$45,068
$4.59 P/Share
|